Przejdź do zawartości
Merck

Is Ross Syndrome a New Type of Synucleinopathy? A Brief Research Report.

Frontiers in neuroscience (2020-08-01)
Mingming Ma, Jing Yao, Yongkang Chen, Han Liu, Danhao Xia, Haiyan Tian, Xinxin Wang, Erxi Wu, Xuejing Wang, Xuebing Ding
ABSTRAKT

Ross syndrome (RS) is a rare peripheral autonomic system disorder characterized by tonic pupil, hyporeflexia, and segmental anhidrosis. Neuropathological studies show that RS results from the selective cholinergic nerve degeneration. However, the cause and underlying mechanisms are largely unknown. Here, we show α-synuclein accumulation in the autonomic nerve terminals in the lesser curvature of stomach of patients with RS. In addition, immunohistochemical findings demonstrate that a dominant degeneration of cholinergic fibers is exhibited in patients with RS, while main degeneration of adrenergic fibers is demonstrated in patients with pure autonomic failure in their gastrointestinal and urinary system. Our study suggests that RS belongs to α-synucleinopathies. Moreover, our findings indicate that adrenergic nerves and cholinergic nerves are not equally damaged in different types of pure autonomic dysfunctions.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Sigma-Aldrich
Anti-phospho-α-Synuclein (Ser129) Antibody, clone 81A, clone 81A, from mouse
Sigma-Aldrich
Anti-Vesicular Acetylcholine Transporter (VAChT) Antibody, from goat, purified by affinity chromatography